{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:49:00Z","timestamp":1782377340709,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.amjcard.2026.04.058","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:54:59Z","timestamp":1777647299000},"page":"152-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Long-Term Outcomes of Dose-Stratified Direct Oral Anticoagulants in Atrial Fibrillation\u2014Results From the Alfred-AF Registry"],"prefix":"10.1016","volume":"271","author":[{"given":"Nicholas","family":"D\u2019Elia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bevacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Dragas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hariharan","family":"Sugumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chieng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Segan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang Han","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"William","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kalman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kistler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr","family":"Voskoboinik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2026.04.058_bib0001","first-page":"k4413","article-title":"Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care","volume":"363","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0002","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jfma.2023.10.014","article-title":"Comparative safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation: A network meta-analysis","volume":"123","author":"Chan","year":"2024","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0003","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000448900","article-title":"Oral anticoagulation in end-stage renal disease: is it time to absolve warfarin?","volume":"44","author":"Genovesi","year":"2016","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0004","article-title":"Effectiveness and safety of under or over-dosing of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 148909 patients from 10 real-world studies","volume":"12","author":"Shen","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s43044-021-00194-1","article-title":"Direct comparison of non-vitamin K antagonist oral anticoagulant versus warfarin for stroke prevention in non-valvular atrial fibrillation: a systematic review and meta-analysis of real-world evidences","volume":"73","author":"Waranugraha","year":"2021","journal-title":"Egypt Heart J"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0006","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijcard.2017.07.043","article-title":"Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: providing evidence for shared decision-making","volume":"245","author":"Noseworthy","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0007","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/heartjnl-2020-318753","article-title":"Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation","volume":"108","author":"Rutherford","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0008","article-title":"Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis","volume":"359","author":"L\u00f3pez-L\u00f3pez","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0009","article-title":"Comparative analysis of the net clinical benefit of direct oral anticoagulants in atrial fibrillation: systematic review and network meta-analysis of randomised controlled trials","volume":"20","author":"Duy Mai","year":"2025","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0010","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0011","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0012","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0013","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0014","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4713826","article-title":"Real-world comparisons of low-dose NOACs versus standard-Dose NOACs or warfarin on efficacy and safety in patients with AF: a meta-analysis","volume":"2022","author":"Li","year":"2022","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/heartjnl-2022-321114","article-title":"Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"109","author":"Caso","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0016","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11239-022-02763-w","article-title":"Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation","volume":"55","author":"Jansson","year":"2023","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0017","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.3390\/jcm10173918","article-title":"Impact of reduced-dose nonvitamin K antagonist oral anticoagulants on outcomes compared to warfarin in Korean patients with atrial fibrillation: a nationwide population-based study","volume":"10","author":"Han","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007633","article-title":"Frequency and outcomes of reduced dose non-vitamin K antagonist anticoagulants: results from ORBIT-AF II (the outcomes registry for better informed treatment of atrial fibrillation II)","volume":"7","author":"Steinberg","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0019","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.japh.2021.10.027","article-title":"Meta-analysis comparing inappropriately low dose versus standard dose of direct oral anticoagulants in patients with atrial fibrillation","volume":"62","author":"Kido","year":"2022","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0020","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.amjmed.2020.12.022","article-title":"Long-term clinical outcomes of underdosed direct oral anticoagulants in patients with atrial fibrillation and atrial flutter","volume":"134","author":"Ashraf","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2026.04.058_bib0021","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1253\/circj.CJ-24-0418","article-title":"Impact of underdosing of direct oral anticoagulants on clinical outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention","volume":"89","author":"Kitahara","year":"2025","journal-title":"Circ J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926003127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926003127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:17:43Z","timestamp":1782375463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914926003127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":21,"alternative-id":["S0002914926003127"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.04.058","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Outcomes of Dose-Stratified Direct Oral Anticoagulants in Atrial Fibrillation\u2014Results From the Alfred-AF Registry","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.04.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}